FDA Inspection 1240371 — Takeda Ireland Limited
The FDA completed an inspection of Takeda Ireland Limited on Jul 14, 2023 in Dublin. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jul 14, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Dublin (Ireland)
Additional details
Mutual Recognition Agreement (MRA)